FOLLOW-UP OF THE PHASE III, MULTICENTRE, NON COMPARATIVE, ONE SINGLE GROUP, OPEN STUDY TO ASSESS THE LONG-TERM EFFICACY AND TOLERABILITY OF PAMOATE OF TRIPTORELIN 11.25 MG IN CHILDREN WITH PRECOCIOUS PUBERTY

Registry ID

EUCTR2008-000565-39

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

BEAUFOUR IPSEN PHARMA

Start date

2008-04-18

Last update

2026-08-16

Conditions

• Precocious Puberty

Summary

To assess the efficacy of triptorelin 11.25 mg with respect to the proportion of children who maintain a regression or stabilisation of sexual maturity until the end of the study.

Locations

• , , France

Related clinical trials

• A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
• Observation of Environment and Reproductive-Endocrine Effects
• Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
• Overweight and Obesity and Puberty Development Cohort Study

View on source registry